aureus colonization
But heres the thing: There are no published clinical trials on GLP-1 microdosing in healthy adults
Front Endocrinol (Lausanne) 14(12):735824 Hidayat K, Du X, Shi BM (2019) Risk of fracture with dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in real-world use: systematic review and meta-analysis of observational studies
1-2
Risk factors for nonalcoholic steatohepatitis include age older than 45 years, an aspartate transaminase (AST) level greater than the alanine transaminase (ALT) level, diabetes, insulin resistance, low albumin level (less than 3.6 g per dL [36 g per L]), low platelet count (less than 100 10 3 per L [100 10 9 per L]), metabolic syndrome, obesity, and portal hypertension on imaging
Athletes calculating whether they can beat the test are making a losing bet